Procedural characteristics and clinical outcomes from same-day discharge after pulsed field ablation treatment for atrial fibrillation: an admIRE trial sub-analysis
Europace · 2025
DOI: 10.1093/europace/euaf270 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Europace, 2025. Verfasst von Luigi Di Biase und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Arrhythmia Center, Division of Cardiology at the Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210 Street, New Yor…. Hauptthemen laut MEDLINE: Ambulatory Surgical Procedures, Atrial Fibrillation, Catheter Ablation, Length of Stay. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biosense Webster, Inc., Johnson and Johnson.
Abstract (Originalsprache)
Aims
Same-day discharge (SDD) following catheter ablation for atrial fibrillation (AF) yields a promising approach to enhance patient satisfaction and reduce healthcare costs. While prior data support the safety of SDD after radiofrequency ablation, evidence following pulsed field ablation (PFA) remains limited. This sub-analysis of the admIRE trial (NCT05293639) evaluates the safety of SDD compared with overnight stays (ONS) after PFA using a variable-loop circular catheter (VLCC). Methods and results Baseline and procedural characteristics, safety, and effectiveness were compared between SDD and ONS groups. Primary effectiveness was defined as freedom from composite failure using Kaplan–Meier estimates. Serious adverse events (SAEs) occurring ≤7 days and ≥1 day post-index procedure were assessed. Amongst 277 patients in the admIRE trial, 119 (43.0%) completed SDD, and 158 (57.0%) stayed overnight. The SDD group included fewer patients aged ≥65 years (41.2% vs. 52.5%), shorter fluoroscopy times (4.0 vs. 8.9 min), higher first-pass isolation rates (97.5% vs. 82.9%), and fewer procedural AEs (1.7% vs. 3.8%). More procedures in the SDD group occurred in the morning (63.0% vs. 39.2%). Freedom from primary effectiveness failure was similar (SDD, 75.4% [95% CI 67.4–83.3%] vs. ONS, 74.0% [95% CI 66.4–81.5%]). No significant difference in SAE risk was observed overall [HR, 1.07 (95% CI 0.47–2.44)] or ≤7 days post-procedure [HR, 0.78 (95% CI 0.17–3.49)]. Post-procedural serious cardiac/vascular AE rates were also comparable (SDD, 2.5% vs. ONS, 1.3%).
Conclusion
SDD is feasible in a paroxysmal AF population undergoing PFA with the VLCC, demonstrating comparable safety and effectiveness outcomes with overnight hospitalization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiac Arrhythmia Center, Division of Cardiology at the Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210 Street, New York, NY 10467, USA.
- Helmsley Electrophysiology Center, Mount Sinai Fuster Heart Hospital, NewYork, NY, USA.
- Memorial Health University Medical Center, Savannah, GA, USA.
- Piedmont Heart Institute, Atlanta, GA, USA.
- St. Bernards Medical Center & Arrhythmia Research Group, Jonesboro, AR, USA.
- Cardiac Arrhythmia Service, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Luigi Di Biase, Vivek Y Reddy, Xiaodong Zhang, David Newton, Sandeep Goyal, Devi Nair, William H Sauer, Christopher F Liu, Jose Osorio, Moussa Mansour, Hugh Calkins, Oussama Wazni, Andrea Natale
Förderung
- Biosense Webster, Inc.
- Johnson and Johnson
Zitieren
APA
Di Biase, L., Reddy, V. Y., Zhang, X., Newton, D., Goyal, S., Nair, D., Sauer, W. H., Iyer, V., Liu, C. F., Osorio, J., Mansour, M., Calkins, H., Wazni, O., & Natale, A. (2025). Procedural characteristics and clinical outcomes from same-day discharge after pulsed field ablation treatment for atrial fibrillation: an admIRE trial sub-analysis. Europace. https://doi.org/10.1093/europace/euaf270
Vancouver
Di Biase L, Reddy VY, Zhang X, Newton D, Goyal S, Nair D, et al. Procedural characteristics and clinical outcomes from same-day discharge after pulsed field ablation treatment for atrial fibrillation: an admIRE trial sub-analysis. Europace. 2025. doi:10.1093/europace/euaf270
BibTeX
@article{DiBiase2025,
author = {Di Biase, Luigi and Reddy, Vivek Y and Zhang, Xiaodong and Newton, David and Goyal, Sandeep and Nair, Devi and Sauer, William H and Iyer, Vivek and Liu, Christopher F and Osorio, Jose and Mansour, Moussa and Calkins, Hugh and Wazni, Oussama and Natale, Andrea},
title = {Procedural characteristics and clinical outcomes from same-day discharge after pulsed field ablation treatment for atrial fibrillation: an admIRE trial sub-analysis},
journal = {Europace},
year = {2025},
doi = {10.1093/europace/euaf270}
}
EUVIMED